What Happened?
St Louis, MO-based C2N-Diagnostics Appointed Joel Braunstein as Chief Executive Officer
About the Company
C2N Diagnostics is a privately-held biotechnology company based in St. Louis, Missouri. We focus on the development of clinical diagnostics and therapeutics for serious brain disorders, with a particular emphasis on Alzheimer`s disease and related forms of progressive neurodegeneration.
About the Person
Joel Braunstein is Chief Executive Officer at C2N Diagnostics. Previously, Joel held various senior HR leadership roles in the industry.
Info Source
News
Short Profile